Logo

NHLBI – FDA Regulatory Science Tools Webinar - Speaker view
Renee Arnold
27:29
Has this started yet?
Brian Buntaine
32:45
Will this recording be available afterwards?
William Hanes
35:21
How does a company qualify for these SEED services?
Wenjie Wei
40:52
Can we have a cope of he slides.
Fahad Saeed
51:45
Are there any standardized workflow that can be used for "AI-based models for diagnosis"?
Fahad Saeed
54:42
What would be the first step for us as a innovator/small business - to get those workflows? Do we contact you?
John Newton
01:07:12
Will the recording be available to show to others in the organization
Lorrain Chien
01:07:42
Where can we order a catalog?
Alexander Everhart
01:08:03
Question for Dr. Margerrison: To what extent has FDA evaluated changes in review times or postmarket performance of devices that use MDDTs in their regulatory submissions?
Fahad Saeed
01:08:28
We have a AI-based model for Mental Disorder Diagnosis - who must we contact to get things rolling at FDA? Is there a co-ordinator or someone who can serve as a primary contact person?
Ajay Houde
01:08:50
How do we request mentor(s) for SBIR Phs II awardee?
Ed Margerrison
01:09:29
The catalog is on our external website at https://www.fda.gov/medical-devices/science-and-research-medical-devices/catalog-regulatory-science-tools-help-assess-new-medical-devices
Ajay Houde
01:11:46
Can the RST be used for implantable class III device?
Daniel Zhu
01:16:25
For Dr. Margerrison: How do you think use of the novel RSTs will affect regulatory approval of a medical device outside the US, particularly for the EU and countries covered by the MDSAP?
Juliet Sidique (She/Her)
01:17:56
Please reach out to nhlbi_sbir@mail.nih.gov regarding product development services and mentoring
Manuel Rivera
01:19:04
Can you provide ballpark figure of the budget one must have when seeking FDA approval for a new medical device?